InvestorsHub Logo
Followers 83
Posts 5662
Boards Moderated 1
Alias Born 10/17/2006

Re: bakersson post# 22578

Friday, 04/21/2017 2:05:30 PM

Friday, April 21, 2017 2:05:30 PM

Post# of 32010
The article refutes what you said about Afrezza not being more effective for mealtime insulin. I don't have the time to respond to all your imaginary interpretations of known facts.

This is the complete study: http://www.mannkindcorp.com/assets/Heinmann-JDiabSciTech-2017.pdf

You think it's more effective because it's fact acting. Mannkind reports that 38% of patients need an extra dose because it doesn't last long enough.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MNKD News